Skip to main content
SleepCited

Using Cannabis and CBD to Sleep: An Updated Review.

Isobel Lavender, Grace Garden, Ronald R Grunstein, Brendon J Yee, Camilla M Hoyos
Review Current psychiatry reports 2024 8 인용
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'pmid\u003D39612156'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

연구 유형
Review
대상 집단
Insomnia patients
중재
Using Cannabis and CBD to Sleep: An Updated Review. None
대조군
None
일차 결과
None
효과 방향
Neutral
비뚤림 위험
Unclear

Abstract

PURPOSE OF REVIEW: Cannabis sativa and constituent cannabinoids are in widespread use for the treatment of sleep disorders where many patients desire pharmacotherapy. Previous reviews highlight a lack of high-quality evidence to support the efficacy and long-term safety of cannabinoids in various conditions. We aim to provide an update of recent original research evaluating cannabinoid-based therapeutics in sleep disorders. RECENT FINDINGS: We identified twenty-one recent studies of cannabinoids for insomnia, subjective sleep impairment, obstructive sleep apnoea, rapid eye movement sleep behaviour disorder, and restless legs syndrome. We note trends towards the use of minor cannabinoids, studies using decentralised approaches and increased utilisation of objective measures in clinical trials. The evidence-base does not match widespread use of cannabinoids for the treatment of sleep disorders. There is a growing need for adequately funded well-designed clinical trials with longer treatment durations and decent sample sizes to inform both the clinician and patient.

요약

The evidence-base does not match widespread use of cannabinoids for the treatment of sleep disorders and there is a growing need for adequately funded well-designed clinical trials with longer treatment durations and decent sample sizes to inform both the clinician and patient.

Used In Evidence Reviews

Similar Papers